These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36077487)

  • 1. Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease.
    Chang LS; Chen KD; Huang YH; Kuo HC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
    Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Eosinophils Subtypes and Their Survivability in Asthma Patients.
    Januskevicius A; Jurkeviciute E; Janulaityte I; Kalinauskaite-Zukauske V; Miliauskas S; Malakauskas K
    Cells; 2020 May; 9(5):. PubMed ID: 32443594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease.
    Huang YH; Chen KD; Lo MH; Cai XY; Chang LS; Kuo YH; Huang WD; Kuo HC
    Int J Med Sci; 2019; 16(4):576-582. PubMed ID: 31171909
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
    Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
    Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
    J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junction protein ZO-1 in Kawasaki disease.
    Lai WT; Lee HC; Huang YH; Lo MH; Kuo HC
    BMC Pediatr; 2021 Mar; 21(1):157. PubMed ID: 33789621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset.
    Chang LS; Guo MM; Yan JH; Huang YH; Lo MH; Kuo HC
    Pediatr Allergy Immunol; 2020 Jul; 31(5):554-559. PubMed ID: 32073687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.
    Furuno K; Takada H; Yamamoto K; Ikeda K; Ohno T; Khajoee V; Mizuno Y; Hara T
    J Pediatr; 2007 Aug; 151(2):155-60, 160.e1. PubMed ID: 17643768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing coronary artery lesions in Kawasaki disease.
    Kuo HC
    Biomed J; 2017 Jun; 40(3):141-146. PubMed ID: 28651735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.
    Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y
    Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
    Kim HJ; Choi EH; Kil HR
    J Korean Med Sci; 2014 Oct; 29(10):1385-90. PubMed ID: 25368492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.